Literature DB >> 12505695

Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.

Harald H O Schmid1, Patricia C Schmid, Evgueni V Berdyshev.   

Abstract

The major endocannabinoids, anandamide (N-arachidonoylethanolamide, 20:4n-6 N-acylethanolamine) and 2-arachidonoylglycerol (2-AG) are structurally and functionally similar, but they are produced by different metabolic pathways and their levels must therefore be regulated by different mechanisms. Both endocannabinoids are accompanied by cannabinoid receptor-inactive, saturated and mono- or di-unsaturated congeners which can influence their metabolism and function. Here we review published data on the presence and production of anandamide and 2-AG and their congeners in mammalian cells and discuss this information in terms of their proposed signaling functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505695     DOI: 10.1016/s0009-3084(02)00157-3

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  13 in total

Review 1.  The endocannabinoid system: a general view and latest additions.

Authors:  Luciano De Petrocellis; Maria Grazia Cascio; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

2.  Levels of N-acylethanolamines in human tumors: in search of reliable data.

Authors:  Mauro Maccarrone; Filomena Fezza; Alessandro Finazzi-Agrò
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

3.  Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo.

Authors:  Jo Begbie; Patrick Doherty; Anthony Graham
Journal:  J Anat       Date:  2004-09       Impact factor: 2.610

4.  Pitfalls in the sample preparation and analysis of N-acylethanolamines.

Authors:  Christian Skonberg; Andreas Artmann; Claus Cornett; Steen Honoré Hansen; Harald S Hansen
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

5.  Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.

Authors:  Yasuo Okamoto; Jun Morishita; Jun Wang; Patricia C Schmid; Randy J Krebsbach; Harald H O Schmid; Natsuo Ueda
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

6.  2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells.

Authors:  Qing Zhao; Zhiwei He; Nanyue Chen; Yong-Yeon Cho; Feng Zhu; Chengrong Lu; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

7.  Lipid profiling reveals tissue-specific differences for ethanolamide lipids in mice lacking fatty acid amide hydrolase.

Authors:  Aruna Kilaru; Giorgis Isaac; Pamela Tamura; David Baxter; Scott R Duncan; Barney J Venables; Ruth Welti; Peter Koulen; Kent D Chapman
Journal:  Lipids       Date:  2010-08-17       Impact factor: 1.880

8.  N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.

Authors:  Kazuhito Tsuboi; Christine Hilligsmann; Séverine Vandevoorde; Didier M Lambert; Natsuo Ueda
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

9.  Miscibility and phase behavior of N-acylethanolamine/diacylphosphatidylethanolamine binary mixtures of matched acyl chainlengths (N=14, 16).

Authors:  Ravi Kanth Kamlekar; S Satyanarayana; Derek Marsh; Musti J Swamy
Journal:  Biophys J       Date:  2007-03-16       Impact factor: 4.033

10.  Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.

Authors:  Gabor Eros; Saleh Ibrahim; Nikolai Siebert; Mihály Boros; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.